Co-treatment with BEZ235 Enhances Sensitivity of BRCA1-negative Breast Cancer Cells to Olaparib.
2015-07-18

2015. Yi YW, Park JS, Kwak SJ, Seong YS. Anticancer Research 35(7): 3829-38.